| Date Filed | Type | Description |
| 08/18/2023 |
4
| Kelly James Patrick (EVP, CFO and Treasurer) has filed a Form 4 on NOVAVAX INC|
Txns:
| Paid exercise price by delivering 1,143 shares
@ $7.13, valued at
$8.1k
Exercised 2,366 restricted stock units
@ $0 |
|
| 03/14/2023 |
4
| Kelly James Patrick (EVP, CFO and Treasurer) has filed a Form 4 on NOVAVAX INC|
Txns:
| Exercised 4,609 shares
@ $6.52, valued at
$30.1k
Paid exercise price by delivering 2,471 shares
@ $6.52, valued at
$16.1k
Exercised 4,609 restricted stock units
@ $0 |
|
| 03/09/2023 |
4
| Kelly James Patrick (EVP, CFO and Treasurer) has filed a Form 4 on NOVAVAX INC|
Txns:
| Granted 42,350 options to buy
@ $6.97, valued at
$295.2k
Granted 36,670 restricted stock units
@ $0 |
|
| 08/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/18/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/23/2021 |
4
| Kelly James Patrick (Executive Vice-President & CFO) has filed a Form 4 on SUPERNUS PHARMACEUTICALS, INC.|
Txns:
| Granted 15,000 options to buy
@ $29.61, valued at
$444.2k
|
|
| 10/13/2020 |
4
| Kelly James Patrick (Executive Vice-President & CFO) has filed a Form 4 on SUPERNUS PHARMACEUTICALS, INC.|
Txns:
| Granted 135,000 options to buy
@ $21.13, valued at
$2.9M
|
|
| 10/13/2020 |
3
| Kelly James Patrick (Executive Vice-President & CFO) has filed a Form 3 on SUPERNUS PHARMACEUTICALS, INC. |
| 03/04/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/06/2020 |
4
| Kelly James Patrick (EVP & CFO) has filed a Form 4 on Vanda Pharmaceuticals Inc.|
Txns:
| Sold 4,020 shares
@ $15.9418, valued at
$64.1k
|
|
| 03/04/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/01/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/04/2019 |
4
| Kelly James Patrick (EVP & CFO) has filed a Form 4 on Vanda Pharmaceuticals Inc.|
Txns:
| Sold 3,313 shares
@ $26.31, valued at
$87.2k
Sold 1,129 shares
@ $26.939, valued at
$30.4k
Sold 1,619 shares
@ $26.085, valued at
$42.2k
|
|
| 03/02/2018 |
4
| Kelly James Patrick (EVP & CFO) has filed a Form 4 on Vanda Pharmaceuticals Inc.|
Txns:
| Granted 40,000 shares
@ $0
Sold 8,532 shares
@ $18.7192, valued at
$159.7k
Granted 80,000 options to buy
@ $18.85, valued at
$1.5M
|
|
| 01/04/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/17/2016 |
4
| Kelly James Patrick (SVP, CFO, Sec & Treasurer) has filed a Form 4 on Vanda Pharmaceuticals Inc.|
Txns:
| Granted 70,000 options to buy
@ $7.94, valued at
$555.8k
Granted 30,000 restricted stock units
@ $0 |
|
| 01/06/2016 |
4
| Kelly James Patrick (SVP, CFO, Sec & Treasurer) has filed a Form 4 on Vanda Pharmaceuticals Inc.|
Txns:
| Sold 9,564 shares
@ $8.96, valued at
$85.7k
Exercised 4,688 restricted stock units
@ $0
Exercised 2,344 restricted stock units
@ $0
Exercised 5,000 restricted stock units
@ $0 |
|
| 03/12/2015 |
4
| Kelly James Patrick (SVP, CFO, Sec & Treasurer) has filed a Form 4 on Vanda Pharmaceuticals Inc.|
Txns:
| Sold 12,450 shares
@ $10.53, valued at
$131.1k
Exercised 12,500 restricted stock units
@ $0
Exercised 4,687 restricted stock units
@ $0
Exercised 2,344 restricted stock units
@ $0
Exercised 5,000 restricted stock units
@ $0 |
|
| 12/05/2014 |
4
| Kelly James Patrick (SVP, CFO, Sec & Treasurer) has filed a Form 4 on Vanda Pharmaceuticals Inc.|
Txns:
| Granted 60,000 options to buy
@ $12.27, valued at
$736.2k
Granted 20,000 restricted stock units
@ $0 |
|
| 02/20/2014 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/04/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 07/31/2013 |
4
| Kelly James Patrick (SVP, CFO, Sec & Treasurer) has filed a Form 4 on Vanda Pharmaceuticals Inc.|
Txns:
| Exercised 9,375 restricted stock units
@ $0 |
|
| 02/19/2013 |
4
| Kelly James Patrick (SVP, CFO, Sec & Treasurer) has filed a Form 4 on Vanda Pharmaceuticals Inc.|
Txns:
| Paid exercise price by delivering 6,978 shares
@ $3.95, valued at
$27.6k
Exercised 12,500 restricted stock units
@ $0
Exercised 4,687 restricted stock units
@ $0 |
|
| 12/11/2012 |
4
| Kelly James Patrick (SVP, CFO, Sec & Treasurer) has filed a Form 4 on Vanda Pharmaceuticals Inc.|
Txns:
| Granted 56,250 options to buy
@ $3.12, valued at
$175.5k
Granted 18,750 restricted stock units
@ $0 |
|
| 02/21/2012 |
4
| Kelly James Patrick (SVP, CFO, Sec & Treasurer) has filed a Form 4 on Vanda Pharmaceuticals Inc.|
Txns:
| Sold 4,920 shares
@ $4.6736, valued at
$23k
Exercised 12,500 restricted stock units
@ $0 |
|
| 08/30/2011 |
4
| Kelly James Patrick (SVP, CFO, Sec & Treasurer) has filed a Form 4 on Vanda Pharmaceuticals Inc.|
Txns:
| Bought 5,000 shares
@ $5.9904, valued at
$30k
|
|
| 12/21/2010 |
4/A
| Kelly James Patrick (SVP, CFO, Sec & Treasurer) has filed a Form 4 on Vanda Pharmaceuticals Inc.|
Txns:
| Granted 150,000 options to buy
@ $8.27, valued at
$1.2M
|
|
| 12/14/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/13/2010 |
3
| Kelly James Patrick (SVP, CFO, Treasurer & Secretar) has filed a Form 3 on Vanda Pharmaceuticals Inc. |